Peer-Reviewed Publication
medRxiv2026June 11, 2026Journal Article

Corticospinal tract risk modifies motor recovery after minimally invasive surgery for intracerebral hemorrhage: a secondary analysis of MISTIE-III.

Olivia N Murray1,2, David A Jenkins3, Nathan Walborn4, Hiren C Patel5, George Harston6,7, Timothy Cootes3, Catharina Jm Klijn8, Wendy Ziai9, Daniel F Hanley4,10, Ulrike Hammerbeck11, Adrian R Parry-Jones1,2
1Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
2Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust & University of Manchester, Manchester, UK.
3Division of Informatics, Imaging and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
4Brain Injury Outcomes, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
5Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester, UK.
6Brainomix, Oxford, UK.
7Acute Stroke Programme, Oxford University Hospitals NHSFT, Oxford, UK.
8Department of Neurology, Radboud University Medical Center, Nijmegen, Netherlands.
9The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
10Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
11Centre of Human and Applied Physiological Sciences, King's College London, London, UK.

Abstract

OBJECTIVE: Outcome after surgical hematoma evacuation for intracerebral hemorrhage (ICH) depends on hematoma location. As corticospinal tract (CST) integrity affects motor recovery after stroke, we hypothesized that CST integrity drives heterogeneity in surgical outcomes and investigated this in a secondary analysis of MISTIE-III participants. METHODS: Risk of CST injury was categorized into four…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.